Login

Exclusive Interview with Doxa CEO Jan Edöcs at Geneva - Jan Edöcs, CEO, Doxa 00:00:00

Share On Facebook Share On Twitter

Exclusive Interview with Doxa CEO Jan Edöcs at Geneva

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Mike Turi's Essential Financial Tips for College Students
00:10:00
High's High-Resolution Seismic Technology Enhances Mining Exploration and Resource Discovery
00:10:00
Richard Parkhouse and Pine van Wyk from Forsys Metals discussed various aspects of the company's activities and the Nasu uranium project in Namibia.
00:10:00
An Entrepreneur's Journey of Strategy Pivots and Perseverance|Stephen Saad, CEO, Aspen Pharmacare Holdings Ltd.
00:10:00
TD Ameritrade to Schwab Q3 Transition: Scam Alert | Jason Gunkel, Chief Investment Officer, Financial Planner of Syverson Strege
00:10:00
First Impressions and Insights from the One-to-One Mining Conference in New York
00:10:00
Insights from Leading Portfolio Managers and Research Heads at Bloomberg Invest Summit
00:10:00
Interview with Sean Vokes, CEO of Talisman Mining on Assay TV
00:10:00
supporting, mentoring, and investing in companies and startups at all stages of growth|Bill Liao, General Partner, venture fund SOSV
00:10:00
Interview with Ed Clarke, CEO of Yojee Ltd | Ed Clarke, CEO, Yojee LtdYOJ:ASX
00:10:00
Debevoise & Plimpton LLP Honored with The 2019 Jonathan Lippman Award
00:10:00
Presentation Transcript of Roxgold at the One-to-One Conference

© 2017 - Neuhu+